Three-dimensional invasion-linked gene expression analysis reveals a therapeutic vulnerability to inhibition of ALK2/BMP6 signaling in LKB1-mutant lung cancer that can be rapidly translated to the clinic.
Grayson Niemi juggled chemo treatments for testicular cancer and practice sessions for joining Ohio State’s marching band. He made the band and also to the…
Together, Fred Hutchinson Cancer Center and UW Medicine offer screening for people at high risk for lung cancer.
The webinar will focus on international survivorship guidelines surveillance recs on SMN screening- specifically breast and colorectal cancer and will provide more background and rationale…
Santhosh K. Sadashiv, MD, discusses the role of chimeric antigen receptor T-cell therapy in patients with multiple myeloma.
Treatment with eflornithine led to clinically meaningful improvements in overall survival (OS) and progression-free survival (PFS) for patients with recurrent grade 3 IDH-mutant astrocytoma, an…
Since European LeukemiaNet (ELN) acute myeloid leukemia (AML) genetic risk classification systems are based on patients treated with intensive chemotherapy
FDA recently approved Alternative Standard #25 related to the Mammography Quality Standards Act. Alternative Standard #25 allows the interpreting physician to provide an assessment of…
This cohort study examines the risk of radiation-associated sarcoma in patients with breast cancer harboring germline TP53 variants.
An abstract is unavailable.
